Back to Search
Start Over
A global respiratory perspective on the COVID-19 pandemic: commentary and action proposals.
- Source :
-
The European respiratory journal [Eur Respir J] 2020 Jul 23; Vol. 56 (1). Date of Electronic Publication: 2020 Jul 23 (Print Publication: 2020). - Publication Year :
- 2020
-
Abstract
- Competing Interests: Conflict of interest: T. To has nothing to disclose. Conflict of interest: G. Viegi has nothing to disclose. Conflict of interest: A. Cruz has nothing to disclose. Conflict of interest: L. Taborda-Barata reports honoraria from AstraZeneca, Novartis, Menarini and Vitoria Laboratories as payment for giving scientific lectures in the context of training sessions in the respiratory field or allergy, for healthcare professionals. Conflict of interest: M. Asher has nothing to disclose. Conflict of interest: D. Behera has nothing to disclose. Conflict of interest: K. Bennoor has nothing to disclose. Conflict of interest: L-P. Boulet has nothing to disclose. Conflict of interest: J. Bousquet reports personal fees for advisory board work, consultancy and lectures from Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Purina, Sanofi-Aventis, Takeda, Teva and Uriach, and owns shares in KYomed-Innov, outside the submitted work. Conflict of interest: P. Camargos has nothing to disclose. Conflict of interest: C. Conceiçao has nothing to disclose. Conflict of interest: S. Gonzalez Diaz has nothing to disclose. Conflict of interest: A. El-Sony has nothing to disclose. Conflict of interest: M. Erhola has nothing to disclose. Conflict of interest: M. Gaga reports grants and personal fees from Novartis and Menarini, grants from Galapagos and Elpen, personal fees from BMS, MSD and AZ, outside the submitted work. Conflict of interest: D. Halpin reports personal fees from AstraZeneca, Chiesi, GlaxoSmithKline, Novartis, Pfizer and Sanofi, personal fees and non-financial support from Boehringer Ingelheim and Novartis, outside the submitted work. Conflict of interest: L. Harding has nothing to disclose. Conflict of interest: T. Maglakelidze has nothing to disclose. Conflict of interest: M.R. Masjedi has nothing to disclose. Conflict of interest: Y. Mohammad has nothing to disclose. Conflict of interest: E. Nunes has nothing to disclose. Conflict of interest: B. Pigearias has nothing to disclose. Conflict of interest: T. Sooronbaev has nothing to disclose. Conflict of interest: R. Stelmach reports grants from São Paulo Research Foundation and MSD, grants and personal fees from Novartis, grants, personal fees and non-financial support from AstraZeneca and Chiesi, personal fees and non-financial support from Boehringer Ingelheim, outside the submitted work. Conflict of interest: I. Tsiligianni reports grants from Elpen and GSK Hellas, personal fees from Novartis, Boehringer Ingelheim, GSK and Menarini, outside the submitted work. Conflict of interest: L.T. Tuyet Lan has nothing to disclose. Conflict of interest: A. Valiulis has nothing to disclose. Conflict of interest: C. Wang has nothing to disclose. Conflict of interest: S. Williams has nothing to disclose. Conflict of interest: A. Yorgancioglu has nothing to disclose.
- Subjects :
- COVID-19
Coronavirus Infections diagnosis
Coronavirus Infections epidemiology
Coronavirus Infections prevention & control
Humans
Pandemics prevention & control
Pneumonia, Viral diagnosis
Pneumonia, Viral epidemiology
Pneumonia, Viral prevention & control
Asthma complications
Coronavirus Infections complications
Pneumonia, Viral complications
Pulmonary Disease, Chronic Obstructive complications
Subjects
Details
- Language :
- English
- ISSN :
- 1399-3003
- Volume :
- 56
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- The European respiratory journal
- Publication Type :
- Editorial & Opinion
- Accession number :
- 32586874
- Full Text :
- https://doi.org/10.1183/13993003.01704-2020